Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Somaye Arabzadeh(Roozbeh Hospital), Shahin Akhondzadeh(Roozbeh Hospital), Abolfazl Ehyaii(Roozbeh Hospital), Ali Ghaleiha(Hamedan University of Medical Sciences), Atefeh Zeinoddini(Massachusetts General Hospital), Mehdi Hamedi(Roozbeh Hospital), Seyed‐Ali Mostafavi(Roozbeh Hospital)
PubMed
January 1, 2018
Cited by 3
Related Papers
A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence–Powered Ultrasound for Improving Clinical Workflow
|Journal of the American College of Radiology|2019|319
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
|Journal of Affective Disorders|2013|135
RIL-Contour: a Medical Imaging Dataset Annotation Tool for and with Deep Learning
|Journal of Imaging Informatics in Medicine|2019|129